These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25391438)

  • 1. [Oral bioavailability of oncological preparations: the intake conditions are often decisive].
    Weitschies W
    Urologe A; 2014 Dec; 53(12):1772-8. PubMed ID: 25391438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of food effects for oral oncology drugs.
    Ratain MJ
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):397-8. PubMed ID: 22895243
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of diet on the clinical pharmacology of oral antineoplastic agents.
    Ruggiero A; Cefalo MG; Coccia P; Mastrangelo S; Maurizi P; Riccardi R
    Eur J Clin Pharmacol; 2012 Feb; 68(2):115-22. PubMed ID: 21796375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dosage timing on the bioavailability of oral anticancer medications: Is pre-prandial dosing equivalent to post-prandial dosing.
    Yu G; Wu DN; Yu Y; Li GF; Zhou HH
    J Oncol Pharm Pract; 2019 Mar; 25(2):404-408. PubMed ID: 29343152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors.
    Willemsen AE; Lubberman FJ; Tol J; Gerritsen WR; van Herpen CM; van Erp NP
    Drug Discov Today; 2016 Jun; 21(6):962-76. PubMed ID: 26995271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food and oral antineoplastics: more than meets the eye.
    Jain RK; Brar SS; Lesko LJ
    Clin Cancer Res; 2010 Sep; 16(17):4305-7. PubMed ID: 20736331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of anticancer drugs II: the prodrug strategy.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food effects on oral agents.
    Lewis LD
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):589-90. PubMed ID: 17982397
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral delivery of anticancer drugs III: formulation using drug delivery systems.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):99-104. PubMed ID: 22981667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
    Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
    J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study.
    Ricart AD; Sarantopoulos J; Calvo E; Chu QS; Greene D; Nathan FE; Petrone ME; Tolcher AW; Papadopoulos KP
    Clin Cancer Res; 2009 Jun; 15(11):3866-71. PubMed ID: 19458055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral chemotherapy: food-drug interactions].
    Santana Martínez S; Marcos Rodríguez JA; Romero Carreño E
    Farm Hosp; 2015 Jul; 39(4):203-9. PubMed ID: 26276738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the changing paradigm in cancer treatment: oral chemotherapy.
    Aisner J
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S4-7. PubMed ID: 17468157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.
    Saven A; Cheung WK; Smith I; Moyer M; Johannsen T; Rose E; Gollard R; Kosty M; Miller WE; Piro LD
    J Clin Oncol; 1996 Mar; 14(3):978-83. PubMed ID: 8622049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral topotecan: bioavailablity and effect of food co-administration.
    Herben VM; Rosing H; ten Bokkel Huinink WW; van Zomeren DM; Batchelor D; Doyle E; Beusenberg FD; Beijnen JH; Schellens JH
    Br J Cancer; 1999 Jul; 80(9):1380-6. PubMed ID: 10424739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cancer treatment: developments in chemotherapy and beyond.
    O'Neill VJ; Twelves CJ
    Br J Cancer; 2002 Oct; 87(9):933-7. PubMed ID: 12434279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors.
    Falchook GS; Venkatakrishnan K; Sarantopoulos J; Kurzrock R; Mita AC; Fu S; Mita MM; Zhou X; Jung JA; Ullmann CD; Milch C; Rosen LS
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):563-72. PubMed ID: 26073352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors.
    Sparreboom A; de Jonge MJ; Punt CJ; Nooter K; Loos WJ; Porro MG; Verweij J
    Clin Cancer Res; 1998 Aug; 4(8):1915-9. PubMed ID: 9717819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.